GSK Partnership 'Catapults' Cell Therapy Projects in UK
By Nuala Moran
Tuesday, May 28, 2013
LONDON The publicly funded UK center set up to accelerate the commercialization of cell therapies has signed its first deal with big pharma, agreeing to work with GlaxoSmithKline plc on a range of research projects and technical and regulatory strategies for getting products to market.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.